ID

42754

Beschrijving

Study of Safety, Tolerability and Pharmacokinetics of Serelaxin in Japanese Acute Heart Failure (AHF) Patients; ODM derived from: https://clinicaltrials.gov/show/NCT02002702

Link

https://clinicaltrials.gov/show/NCT02002702

Trefwoorden

Versies (2)
  1. 04-12-15 04-12-15 -
  2. 17-09-21 17-09-21 -
Geüploaded op

17 september 2021

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Acute Heart Failure NCT02002702

Engels

Eligibility Acute Heart Failure NCT02002702

1 Formulieren  
Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
written informed consent must be obtained before any study-specific assessment is performed.
Beschrijving

Informed consent

Datatype

boolean

Alias
UMLS CUI [1]
C0021430
male or female ≥20 years of age
Beschrijving

Patient age and sex

Datatype

boolean

Alias
UMLS CUI [1]
C0150831
UMLS CUI [2]
C0001779
hospitalized for ahf; ahf is defined as including all of the followings measured at any time between presentation (including the emergency department) and the end of screening:
Beschrijving

hospitalized for ahf

Datatype

boolean

Alias
UMLS CUI [1]
C0264714
UMLS CUI [2]
C0870668
dyspnea at rest or with minimal exertion
Beschrijving

dyspnea

Datatype

boolean

Alias
UMLS CUI [1,1]
C0013404
UMLS CUI [1,2]
C0231807
pulmonary congestion on chest x-ray,
Beschrijving

pulmonary congestion

Datatype

boolean

Alias
UMLS CUI [1]
C0242073
bnp ≥350 pg/ml or nt-probnp ≥1,400 pg/ml
Beschrijving

bnp ≥350 pg/ml or nt-probnp ≥1,400 pg/ml

Datatype

boolean

Alias
UMLS CUI [1]
C1095989
UMLS CUI [2]
C3272900
sbp ≥125 mmhg at the start and at the end of screening
Beschrijving

sbp ≥125 mmhg at the start and at the end of screening

Datatype

boolean

Alias
UMLS CUI [1]
C0871470
able to be randomized within 16 hours from presentation to the hospital, including the emergency department
Beschrijving

randomized within 16 hours from presentation to the hospital

Datatype

boolean

Alias
UMLS CUI [1]
C1320532
received intravenous (iv) furosemide of at least 40 mg (or equivalent) at any time between presentation (this include outpatient clinic, ambulance, or hospital including emergency department) and the start of screening for the study for the treatment of the current acute heart failure (hf) episode.
Beschrijving

received intravenous (iv) furosemide

Datatype

boolean

Alias
UMLS CUI [1,1]
C0354100
UMLS CUI [1,2]
C1391960
impaired renal function defined as an estimated glomerular filtration rate (egfr) between presentation and randomization of ≥ 25 and≤ 75 ml/min/1.73 m2, calculated using the japanese formula
Beschrijving

impaired renal function

Datatype

boolean

Alias
UMLS CUI [1]
C1565489
with body weight ≥30 kg and ≤160 kg
Beschrijving

body weight

Datatype

text

Alias
UMLS CUI [1]
C0005910
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
dyspnea primarily due to non-cardiac causes
Beschrijving

dyspnea non cardiac

Datatype

boolean

Alias
UMLS CUI [1]
C0013404
temperature >38.5°c (oral or equivalent) or sepsis or active infection requiring iv anti-microbial treatment
Beschrijving

temperature >38.5°c (oral or equivalent) or sepsis or active infection requiring iv anti-microbial treatment

Datatype

boolean

Alias
UMLS CUI [1]
C0015967
clinical evidence of acute coronary syndrome currently or within 30 days prior to enrollment.
Beschrijving

acute coronary syndrome

Datatype

boolean

Alias
UMLS CUI [1]
C0948089
ahf due to significant arrhythmias, which include any of the following: sustained ventricular tachycardia, bradycardia with sustained ventricular rate <45 beats per minute, or atrial fibrillation/flutter with sustained ventricular response of >130 beats per minute.
Beschrijving

significant arrhythmias

Datatype

boolean

Alias
UMLS CUI [1]
C0003811
other protocol defined inclusion/exclusion criteria may apply.
Beschrijving

other protocol defined inclusion/exclusion criteria may apply

Datatype

boolean

Alias
UMLS CUI [1]
C0205394
UMLS CUI [2]
C1516637
Terug naar het begin van de pagina

Similar models

Eligibility Acute Heart Failure NCT02002702

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
Informed consent
Item
written informed consent must be obtained before any study-specific assessment is performed.
boolean
C0021430 (UMLS CUI [1])
Patient age and sex
Item
male or female ≥20 years of age
boolean
C0150831 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
hospitalized for ahf
Item
hospitalized for ahf; ahf is defined as including all of the followings measured at any time between presentation (including the emergency department) and the end of screening:
boolean
C0264714 (UMLS CUI [1])
C0870668 (UMLS CUI [2])
dyspnea
Item
dyspnea at rest or with minimal exertion
boolean
C0013404 (UMLS CUI [1,1])
C0231807 (UMLS CUI [1,2])
pulmonary congestion
Item
pulmonary congestion on chest x-ray,
boolean
C0242073 (UMLS CUI [1])
bnp ≥350 pg/ml or nt-probnp ≥1,400 pg/ml
Item
bnp ≥350 pg/ml or nt-probnp ≥1,400 pg/ml
boolean
C1095989 (UMLS CUI [1])
C3272900 (UMLS CUI [2])
sbp ≥125 mmhg at the start and at the end of screening
Item
sbp ≥125 mmhg at the start and at the end of screening
boolean
C0871470 (UMLS CUI [1])
randomized within 16 hours from presentation to the hospital
Item
able to be randomized within 16 hours from presentation to the hospital, including the emergency department
boolean
C1320532 (UMLS CUI [1])
received intravenous (iv) furosemide
Item
received intravenous (iv) furosemide of at least 40 mg (or equivalent) at any time between presentation (this include outpatient clinic, ambulance, or hospital including emergency department) and the start of screening for the study for the treatment of the current acute heart failure (hf) episode.
boolean
C0354100 (UMLS CUI [1,1])
C1391960 (UMLS CUI [1,2])
impaired renal function
Item
impaired renal function defined as an estimated glomerular filtration rate (egfr) between presentation and randomization of ≥ 25 and≤ 75 ml/min/1.73 m2, calculated using the japanese formula
boolean
C1565489 (UMLS CUI [1])
body weight
Item
with body weight ≥30 kg and ≤160 kg
text
C0005910 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
dyspnea non cardiac
Item
dyspnea primarily due to non-cardiac causes
boolean
C0013404 (UMLS CUI [1])
temperature >38.5°c (oral or equivalent) or sepsis or active infection requiring iv anti-microbial treatment
Item
temperature >38.5°c (oral or equivalent) or sepsis or active infection requiring iv anti-microbial treatment
boolean
C0015967 (UMLS CUI [1])
acute coronary syndrome
Item
clinical evidence of acute coronary syndrome currently or within 30 days prior to enrollment.
boolean
C0948089 (UMLS CUI [1])
significant arrhythmias
Item
ahf due to significant arrhythmias, which include any of the following: sustained ventricular tachycardia, bradycardia with sustained ventricular rate <45 beats per minute, or atrial fibrillation/flutter with sustained ventricular response of >130 beats per minute.
boolean
C0003811 (UMLS CUI [1])
other protocol defined inclusion/exclusion criteria may apply
Item
other protocol defined inclusion/exclusion criteria may apply.
boolean
C0205394 (UMLS CUI [1])
C1516637 (UMLS CUI [2])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial